Journals / The Turkish Journal of Ear Nose and Throat / 2021 / Cilt: 31 - Sayı: 3

The Role of Activin-A in the Etiopathogenesis of Nasal Polyposis

Pages
60–65
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Clearer elucidation of the roles of activin-A and other mediators in tissue remodeling in NP may ensure more accurate targets for treatment and prevention of relapse.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Nasal polyposis (NP) is defined as persistent inflammation of the sinonasal mucosa intractable to medical and surgical treatment.
📊
Key Findings & Data:Activin-A, is a pleiotropic cytokine in the transforming growth factor-b (TGF-β) superfamily and was shown to orchestrate the allergic inflammation in asthma via suppression of T helper-2 (Th2) cells, induction of regulatory T cells, and tissue repair.
💡
Conclusion & Impact:Clearer elucidation of the roles of activin-A and other mediators in tissue remodeling in NP may ensure more accurate targets for treatment and prevention of relapse.
🔬Design:Modeling & Simulation
📍Scope:Comprehensive Sample
⚙️Variables:Activin A · Nasal polyps · Sinusitis

Abstract

Objective: Nasal polyposis (NP) is defined as persistent inflammation of the sinonasal mucosa intractable to medical and surgical treatment. Activin-A, is a pleiotropic cytokine in the transforming growth factor-b (TGF-β) superfamily and was shown to orchestrate the allergic inflammation in asthma via suppression of T helper-2 (Th2) cells, induction of regulatory T cells, and tissue repair. The purpose of this study was to investigate the role of the activin-A in pathophysiology of NP.Materials and Methods: According to the European Rhinosinusitis and Nasal Polyp criteria, 50 patients and 24 healthy subjects were included in the study. There were no significant differences across age and gender between the 2 groups (p>0.05). Samples from patients with NP (n=50; 11 women, 39 men) were acquired during endoscopic sinus surgeries. Middle turbinate specimens from patients without sinus disease and who were undergoing septoplasty were collected as controls (n=24; 3 women, 21 men).Results: Immunohistochemical staining with activin-A showed an increase in the staining intensity, number of glands and inflammatory cells in polyp specimens compared to healthy nasal mucosa. In contrast, no differences were found in fibroblasts and vascular density.Conclusion: We evaluated the expression of activin-A in NP tissue, which showed a slightly elevated expression compared to the controls. This might support the possible role of activin-A in the pathophysiology of NP. Clearer elucidation of the roles of activin-A and other mediators in tissue remodeling in NP may ensure more accurate targets for treatment and prevention of relapse.

🔖

Cite This Article

DAĞISTAN, H., BOZKURT, M. K., ELSÜRER, Ç., KARABAĞLI, P. (2021). The Role of Activin-A in the Etiopathogenesis of Nasal Polyposis. The Turkish Journal of Ear Nose and Throat, Cilt: 31 - Sayı: 3, 60–65. https://ajindex.com/articles/362572

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Stevens WW, Schleimer RP, Kern RC. Chronic Rhinosinusitis with Nasal Polyps. J Allergy Clin Immunol Pract 2016
  2. 4(4):565-72. google scholar 2. Gelardi M, Iannuzzi L, Tafuri S, Passalacqua G, Quaranta N. Allergic and non-allergic rhinitis: relationship with nasal polyposis, asthma and family history. Acta Otorhinolaryngol Ital 2014
  3. 34(1):36-41. google scholar 3. Cao PP, Li HB, Wang BF, Wang SB, You XJ, Cui YH, et al. Distinct immunopathologic characteristics of various types of chronic rhinosinusitis in adult Chinese. J Allergy Clin Immunol 2009
  4. 124(3):478-84. google scholar 4. Bachert C, Gevaert P, Holtappels G, Cuvelier C, van Cauwenberge P: Nasal polyposis: from cytokines to growth. Am J Rhinol 2000
  5. 14(5):279-90. google scholar 5. Hammad H, Lambrecht BN. Dendritic cells and epithelial cells: linking innate and adaptive immunity in asthma. Nat Rev Immunol 2008
  6. 8(3):193-204. google scholar 6. Alcorn JF, Rinaldi LM, Jaffe EF, van Loon M, Bates JH, Janssen-Heininger YM, et al. Transforming growth factor-beta1 suppresses airway hyperresponsiveness in allergic airway disease. Am J Respir Crit Care Med 2007
  7. 176(10):974-82. google scholar 7. Kou W, Guo-Hua H, Yao H-B, Wang X, Shen Y, Kang H-Y, et al. Regulation of transforming growth factor-1 activation and expression in the tissue remodeling involved in chronic rhinosinusitis. ORLJOtorhinolaryngolRelatSpec 2012
  8. 74(3):172-8. google scholar 8. Hirschberg A, Jokuti A, Darvas Z, Almay K, Repassy G, Falus A. Pathogenesis of nasal polyposis by immunoglobulin E and interleukin-5 is complete by transforming growth factor-B1. Laryngoscope 2003
  9. 113(1):120-4. google scholar 9. Yang Y, Zhang N, Lan F, Van Crombruggen K, Fang L, Hu G, et al. Transforming growth factorbeta1 pathways in inflammatory airway diseases. Allergy 2014
  10. 69(6):699-707. google scholar 10. Hedger MP, Kretser de DM. The activins and their binding protein, follistatin-Diagnostic and therapeutic targets in inflammatory disease and fibrosis. Cytokine Growth Factor Rev 2013
  11. 24(3):285-95. google scholar 11. Gregory LG, Mathie SA, Walker SA, Pegorier S, Jones CP, Lloyd CM. Overexpression of Smad2 drives house dust mite-mediated airway remodeling and airway hyperresponsiveness via activin and IL-25. Am J Respir Crit Care Med 2010
  12. 182(2):143-54. google scholar 12. Karagiannidis C, Hense G, Martin C, Epstein M, Ruckert B, Mantel PY et al. Activin A is an acute allergen-responsive cytokine and provides a link to TGF-beta-mediated airway remodeling in asthma. J A